Improving Response Inhibition in Parkinson's Disease with Atomoxetine

Ye Zheng; Altena Ellemarije; Nombela Cristina; Housden Charlotte R.; Maxwell Helen; Rittman Timothy; Huddleston Chelan; Rae Charlotte L.; Regenthal Ralf; Sahakian Barbara J.; Barker Roger A.; Robbins Trevor W.; Rowe James B.

首页> 外文期刊>Biological psychiatry >Improving Response Inhibition in Parkinson's Disease with Atomoxetine

【24h】

Improving Response Inhibition in Parkinson's Disease with Atomoxetine

机译：用阿托莫西汀改善帕金森氏病的反应抑制

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUND: Dopaminergic drugs remain the mainstay of Parkinson's disease therapy but often fail to improve cognitive problems such as impulsivity. This may be due to the loss of other neurotransmitters, including noradrenaline, which is linked to impulsivity and response inhibition. We therefore examined the effect of the selective noradrenaline reuptake inhibitor atomoxetine on response inhibition in a stop-signal paradigm.

机译：背景：多巴胺能药物仍然是帕金森氏病治疗的主要手段，但常常无法改善冲动等认知问题。这可能是由于其他神经递质的损失，包括去甲肾上腺素，与冲动性和反应抑制有关。因此，我们研究了停止信号范式中选择性去甲肾上腺素再摄取抑制剂托莫西汀对反应抑制的影响。

著录项

来源
《Biological psychiatry》 |2015年第8期|共9页
作者
Ye Zheng; Altena Ellemarije; Nombela Cristina; Housden Charlotte R.; Maxwell Helen; Rittman Timothy; Huddleston Chelan; Rae Charlotte L.; Regenthal Ralf; Sahakian Barbara J.; Barker Roger A.; Robbins Trevor W.; Rowe James B.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词
Atomoxetine; Impulsivity; Noradrenaline; Parkinson's disease; Response inhibition; SSRT;

机译：阿托西汀;冲动;去甲肾上腺素;帕金森病;反应抑制;SSRT;

相似文献

外文文献
中文文献
专利

1. Improving Response Inhibition in Parkinson's Disease with Atomoxetine [J] . Ye Zheng, Altena Ellemarije, Nombela Cristina, Biological psychiatry . 2015,第8期

机译：用阿托莫西汀改善帕金森氏病的反应抑制
2. Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures [J] . Ye Zheng, Rae Charlotte L., Nombela Cristina, Human brain mapping . 2016,第3期

机译：通过临床和神经影像学方法预测阿托西汀和西酞普兰对帕金森氏病反应抑制的有益作用
3. Atomoxetine Does Not Improve Complex Attention in Idiopathic Parkinson’s Disease Patients with Cognitive Deficits: A Meta-Analysis [J] . Abhinaba Ghosh, Saibal Das, Sapan Kumar Behera, Parkinson’s Disease . 2020,第2期

机译：奥昔昔汀在特发性帕金森病患者的认知赤字患者中没有提高复杂关注：Meta分析
4. The glial inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: Relevance to progression of the disease [C] . J.L. Labandeira-Garcia, B. Joglar, J. Rodriguez-Pallares, European Meeting on Glial Cells in Health and Disease . 2009

机译：帕金森病的MPTP模型中的胶质炎症反应是由脑血管紧张素的介导的：与疾病的进展相关
5. The role of pesticide-induced aldehyde dehydrogenase inhibition in the pathogenesis of Parkinson's disease. [D] . Fitzmaurice, Arthur G. 2012

机译：农药诱导的醛脱氢酶抑制作用在帕金森氏病发病机理中的作用。
6. Improving Response Inhibition in Parkinson’s Disease with Atomoxetine [O] . Zheng Ye, Ellemarije Altena, Cristina Nombela, -1

机译：用阿托莫西汀改善帕金森氏病的反应抑制
7. Improving Response Inhibition in Parkinson’s Disease with Atomoxetine [O] . Ye Zheng, Altena Ellemarije, Nombela Cristina, 2015

机译：用阿托莫西汀改善帕金森氏病的反应抑制

Improving Response Inhibition in Parkinson's Disease with Atomoxetine

摘要

著录项

相似文献

相关主题

期刊订阅